KospicyKorean filings in English
Filings / D&D Pharmatech

Acquisition of Shares in Another Company

D&D Pharmatech · 타법인주식및출자증권취득결정

8-KKOSDAQ · 347850 Filed 2026-11-12Korean original on DART

English form view 50% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Decision to acquire shares and equity securities of another company

1. IssuerCompany name (nationality)Z-Alpha Holdings, Inc.

(미국) | 대표이사 | Kevin Bunker |
|---|---|---|---|---|
| Capital (KRW) | 8,758,630 | Relationship to Company | Other related parties |
| Total Shares Issued (shares) | 61,181,190 | Principal business | 의약품 연구개발업 |
| -New shares acquired via 3-party allotment within last 6 months | No |
| 2. Acquisition Details | Shares acquired (shares) | 4,299,965 |
| Acquisition Amount (KRW) | 10,025,248,610 |
| Equity (KRW) | 91,913,078,098 |
| % of Equity | 10.91 |
| Large Enterprise | N/A |
| 3. Shares Held and Ownership Ratio After Acquisition | Shares Owned (shares) | 4,299,965 |
| Ownership (%) | 4.75 |
| 4. Acquisition Method | Cash acquisition |
| 5. Purpose of Acquisition | 미국 알파 방사성 치료제 개발사 자금조달 참여를 통한 영향력 강화 |
| 6. Planned Acquisition Date | 2026-11-16 |
| 7. Subject to material event report on asset acquisition | No |
| -Total assets at latest fiscal year-end (KRW) | 97,539,472,152 | Acquisition price / total assets (%) | 10.28 |
| 8. Backdoor Listing | No |
| -Plans for third-party allotment capital increase etc. within 6 months (3) | No |
| 9. Issuer (other company) meets backdoor listing criteria | N/A |
| 10. Board Resolution Date (Decision Date) | 2026-11-12 |
| - Outside Directors Present | Present (persons) | 1 |
| Absent (persons) | 1 |
| - Auditor (Audit Committee Member) Attendance | Present |
| 11. Subject to KFTC Filing | N/A |
| 12. Put Option Agreements, etc. | No |
| - Contract Details | - |
| 13. Other Matters Relevant to Investment Decisions | 1) 상기 '1.발행회사'의 '자본금(원)' 및 '1.발행주식총수(주)'은 2025년말 기준입니다. 2) 상기 '1.발행회사'의' 2.취득내역'의 '취득금액(원)'은 외화 취득금액 USD 7,499,998.96을 이사회 당일 서울외국환중개(주) 최초고시 매매기준율(USD 1 = \ 1,336.70)을 적용하여 환산하였습니다. 3) 상기 '2.취득내역'의 자기자본은 당사의 최근사업연도말 자기자본에서 자본금 및 자본잉여금의 증감을 반영하였습니다. 4) 상기 '3. 취득후 소유주식수 및 지분비율'에서 당사가 취득하는 주식은 발행회사의 우선주 입니다. 5) 상기 '6.취득예정일자'는 납입일정에 따라 최종 납입이 완료되는 예상일자를 기재하였으며, 관계법령상의 신고 및 관계기관과의 협의 과정에서 변동될 수 있습니다. 6) 상기 '7. 자산양수의 주요사항보고서 제출대상 여부'의 아니오 사유는 구주 취득이 아닌 신주발행 취득 사유로 주요사항보고서 제출 대상이 아닙니다. 7) 하기 '발행회사의 요약 재무상황' 당해 연도는 2025년 말 재무제표 기준이며, 전년도는 2024년말, 전전년도는 2023년말 기준입니다. 재무상황의 동일성을 위해 2025년 말 서울외국환중개 최초 고시 환율로 환산하여 기재하였습니다. [1 USD = 1,434.90] 8) 하기 '상대방에 관한 사항' 중 재무상황은 2025년말 기준이며, 2025년말 서울외국환중개 최초 고시 환율로 환산하여 기재하였습니다. [1 USD = 1,434.90] |

[Issuer's Summary Financial Position]

(Unit: KRW m)

CategoryTotal AssetsTotal LiabilitiesTotal EquityPaid-in CapitalRevenueNet Income
Current year93,1255,16687,9599--29,702
Prior Year119,9583,587116,3709--20,663
Two Years Prior103,1694,73598,4349--16,071

[Counterparty Information]

1. Personal Information
- General Information
Name (Entity Name)NationalityAddress (Head Office) [Town/District Level Only]Date of Birth (Business Registration No., etc.)
Z-Alpha Holdings, Inc.United StatesWilmington, Delaware-
Occupation (business)의약품 연구개발업
- Largest Shareholder, CEO, Representative Executive Officer and Financial Condition (if counterparty is a corporation)
CategoryNameNumber of SharesOwnership (%)
Largest ShareholderTybourne Capital Management (HK) Limited18,398,51630.07
Largest ShareholderORBIMED ASIA PARTNERS IV, L.P.18,398,51630.07
(Unit: KRW m)
Relevant fiscal year2025Fiscal year-endMonth 12
Total Assets93,125Paid-in Capital9
Total Liabilities5,166Revenue-
Total Equity87,959Net income (loss)-29,702
External Auditor-Business suspendedNo
Audit Opinion-Business closedNo
2. Relationship with Counterparty
1. Relationship between Company and CounterpartyOther related parties
2. Relationship between Company's Largest Shareholder/Officers and CounterpartyNameRelationship with Counterparty
CEO이슬기발행회사 등기이사
3. Transactions in Past 3 Years (excl. Ordinary Transactions)
CategoryTransaction Details
Current year-
Prior Year-
Two Years Prior-